Onco-Innovations Limited (NEO:ONCO)
Canada flag Canada · Delayed Price · Currency is CAD
2.070
+0.020 (0.98%)
Jul 23, 2025, 4:00 PM EDT

Onco-Innovations Company Description

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology.

Onco-Innovations Limited is headquartered in Calgary, Canada.

Onco-Innovations Limited
CountryCanada
IndustryBiological Products, Except Diagnostic Substances
Employees1
CEOThomas O’Shaughnessy

Contact Details

Address:
7th Street SW
Calgary, British Columbia T2R 1A5
Canada
Phone848-488-9277
Websiteoncoinnovations.com

Stock Details

Ticker SymbolONCO
ExchangeCboe Canada
Fiscal YearMay - April
Reporting CurrencyCAD
SIC Code2836

Key Executives

NamePosition
Thomas O’ShaughnessyChief Executive Officer
Nico MahChief Financial Officer